dc.contributor.author
Viñals Álvarez, Xavier, 1985-
dc.contributor.author
Maldonado, Rafael, 1961-
dc.contributor.author
Robledo, Patricia, 1958-
dc.date.issued
2015-03-31T10:18:06Z
dc.date.issued
2015-03-31T10:18:06Z
dc.identifier
Viñals X, Maldonado R, Robledo P. Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice. Addiction Biology. 2013;18(2):263-73. DOI: 10.1111/j.1369-1600.2011.00421.x
dc.identifier
http://hdl.handle.net/10230/23316
dc.identifier
http://dx.doi.org/10.1111/j.1369-1600.2011.00421.x
dc.description.abstract
Repeated administration of 3,4-methylenedioxymethamphetamine (MDMA) produces dopaminergic neurotoxicity in mice. However, it is still not clear whether this exposure induces deficits in cognitive processing related to specific subsets of executive functioning. We evaluated the effects of neurotoxic and non-neurotoxic doses of MDMA (0, 3 and 30 mg/kg, twice daily for 4 days) on working memory and attentional set-shifting in mice, and changes in extracellular levels of dopamine (DA) in the striatum. Treatment with MDMA (30 mg/kg) disrupted performance of acquired operant alternation, and this impairment was still apparent 5 days after the last drug administration. Decreased alternation was not related to anhedonia because no differences were observed between groups in the saccharin preference test under similar experimental conditions. Correct responding on delayed alternation was increased 1 day after repeated treatment with MDMA (30 mg/kg), probably because of general behavioural quiescence. Notably, the high dose regimen of MDMA impaired attentional set-shifting related to an increase in total perseveration errors. Finally, basal extracellular levels of DA in the striatum were not modified in mice repeatedly treated with MDMA with respect to controls. However, an acute challenge with MDMA (10 mg/kg) failed to increase DA outflow in mice receiving the highest MDMA dose (30 mg/kg), corroborating a decrease in the functionality of DA transporters. Seven days after this treatment, the effects of MDMA on DA outflow were recovered. These results suggest that repeated neurotoxic doses of MDMA produce lasting impairments in recall of alternation behaviour and reduce cognitive flexibility in mice.
dc.description.abstract
This work was supported by the DG Research of the European Commission (PHECOMP: LHSM-CT-2007-037669), the Spanish ‘Instituto de Salud Carlos III’ (RD06/001/001 and PI070709), FEDER funds, and ‘Ministerio de Ciencia e Innovación’ (SAF2007-64062), the Catalan government (SGR2009-00131) and the ICREA Foundation (ICREA Academia-2008)
dc.format
application/pdf
dc.format
application/pdf
dc.publisher
Wiley-Blackwell
dc.relation
Addiction Biology. 2013;18(2):263-73
dc.relation
info:eu-repo/grantAgreement/EC/FP6/037669
dc.relation
info:eu-repo/grantAgreement/ES/2PN/SAF2007-64062
dc.rights
© Wiley-Blackwell. The definitive version is available at www3.interscience.wiley.com
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Animals -- Hàbits i conducta
dc.subject
Èxtasi (Droga)
dc.title
Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion